Background: Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a transformative approach in cancer treatment, showing significant efficacy in hematologic cancers. However, its application in solid tumors is limited due to challenges such as the tumor microenvironment and antigen heterogeneity. This review aims to highlight the efficacy, safety, and challenges of CAR و...